HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases.

Abstract
CD30 expression is the hallmark of the cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and anaplastic large cell lymphoma. We report CD30 expression in cutaneous follicle center cell lymphoma and in cutaneous post-transplant peripheral T-cell lymphoma. Histopathologists should be aware of CD30 expression in cutaneous lymphomas outside the realm of so-called CD30+ lymphoproliferative disorders to avoid diagnostic errors and improper medical treatment.
AuthorsHana Albrecht, Janet M Woodroof, Ruben Reyes, Benjamin C Powers, Garth R Fraga
JournalDermatology online journal (Dermatol Online J) Vol. 20 Issue 7 (Jul 15 2014) ISSN: 1087-2108 [Electronic] United States
PMID25046457 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ki-1 Antigen
Topics
  • Aged
  • B-Lymphocytes (immunology, metabolism, pathology)
  • Biopsy
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Ki-1 Antigen (biosynthesis, immunology)
  • Lymphoma, T-Cell, Peripheral (immunology, metabolism, pathology)
  • Middle Aged
  • Prognosis
  • Skin (immunology, pathology)
  • Skin Neoplasms (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: